99% Goserelin for prostate cancer CAS 65807-02-5

Quick Details Port: China main port Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram Supply Ability: 1000 Kilogram/Kilograms per Month Sample: Available Grade: Phamaceutical Grade Appearance: White powder Certification: ISO 9001 COA MSDS MOQ: 1kg CAS No.: 65807-02-5 Type: Vitamins, Amino Acids and Coenzymes Test Method: HPLC Storage: Cool Dry Place with sealed container Shelf Life: 2 Years Properly Stored Package: 1kg/bag, 25kg/drum Application: Pharma use to treat prostate cancer. Packaging Detail: 25kg/Drum or according to customer’s requirements 99% Goserelin for prostate cancer CAS 65807-02-5 Goserelin (INN, USAN, BAN) (brand name Zoladex, by AstraZeneca), or goserelin acetate, is a drug used to suppress production of the sex hormones (testo sterone and estrogen), particularly in the treatment of breast and prostate cancer. It is an injectable gonadotropin releasing hormone superagonist (GnRH agonist), also known as a luteinizing hormone releasing hormone (LHRH) agonist. Structurally, it is a decapeptide. It is the natural LHRH/GnRH decapeptide with two substitutions to inhibit rapid degradation. Goserelin stimulates the production of the sex hormones testo sterone and estrogen in a non-pulsatile (non-physiological) manner. This causes the disruption of the endogenous hormonal feedback systems, resulting in the down-regulation of testo sterone and estrogen production.   Product Name: Goserelin Appearance white powder CAS NO. […]